Risk factor
Weak & very vulnerable to price shocks
Profitability factor
Strong margins and returns
About
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair
Target Price
The average target price of 0867.HK is 17 and suggests 29% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell